Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura H Tang

Showing results (91-100 of 172) with videos related to

Pageof 18
Sort By:
The American Journal of Surgical Pathology|August 8, 2008
Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendixLaura H Tang, Jinru Shia, Robert A Soslow, et al.
Human Pathology|April 20, 2007
Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significanceAnne Lin, Martin R Weiser, David S Klimstra, et al.
Annals of Surgery|January 31, 2013
Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expressionJordan M Winter, Laura H Tang, David S Klimstra, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 25, 2012
Secondary mutation in a coding mononucleotide tract in MSH6 causes loss of immunoexpression of MSH6 in colorectal carcinomas with MLH1/PMS2 deficiencyJinru Shia, Liying Zhang, Moshe Shike, et al.
Annals of Surgical Oncology|February 10, 2021
Outcomes of Neoadjuvant Chemotherapy for Clinical Stages 2 and 3 Gastric Cancer Patients: Analysis of Timing and Site of RecurrenceMasaya Nakauchi, Elvira Vos, Laura H Tang, et al.
Annals of Surgical Oncology|April 8, 2021
Association of Obesity with Worse Operative and Oncologic Outcomes for Patients Undergoing Gastric Cancer ResectionMasaya Nakauchi, Elvira L Vos, Laura H Tang, et al.
Cancer Immunology Research|January 9, 2025
Host Tissue Factors Predict Immune Surveillance and Therapeutic Outcomes in Gastric CancerMiseker Abate, Emily E Stroobant, Teng Fei, et al.
Diseases of the Colon and Rectum|July 31, 2007
Squamous-cell carcinoma of the rectum: a rare but curable tumorCaio S R Nahas, Jinru Shia, Romane Joseph, et al.
Annals of Surgery|November 17, 2020
A More Extensive Lymphadenectomy Enhances Survival After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal AdenocarcinomaSmita Sihag, Tamar Nobel, Meier Hsu, et al.
Annals of Surgical Oncology|December 28, 2013
Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancersDo Joong Park, Changhwan Yoon, Nicholas Thomas, et al.
Pageof 18

Showing results (91-100 of 172) with videos related to

Sort By:
Pageof 18
The American Journal of Surgical Pathology|August 8, 2008
Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendixLaura H Tang, Jinru Shia, Robert A Soslow, et al.
Human Pathology|April 20, 2007
Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significanceAnne Lin, Martin R Weiser, David S Klimstra, et al.
Annals of Surgery|January 31, 2013
Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expressionJordan M Winter, Laura H Tang, David S Klimstra, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 25, 2012
Secondary mutation in a coding mononucleotide tract in MSH6 causes loss of immunoexpression of MSH6 in colorectal carcinomas with MLH1/PMS2 deficiencyJinru Shia, Liying Zhang, Moshe Shike, et al.
Annals of Surgical Oncology|February 10, 2021
Outcomes of Neoadjuvant Chemotherapy for Clinical Stages 2 and 3 Gastric Cancer Patients: Analysis of Timing and Site of RecurrenceMasaya Nakauchi, Elvira Vos, Laura H Tang, et al.
Annals of Surgical Oncology|April 8, 2021
Association of Obesity with Worse Operative and Oncologic Outcomes for Patients Undergoing Gastric Cancer ResectionMasaya Nakauchi, Elvira L Vos, Laura H Tang, et al.
Cancer Immunology Research|January 9, 2025
Host Tissue Factors Predict Immune Surveillance and Therapeutic Outcomes in Gastric CancerMiseker Abate, Emily E Stroobant, Teng Fei, et al.
Diseases of the Colon and Rectum|July 31, 2007
Squamous-cell carcinoma of the rectum: a rare but curable tumorCaio S R Nahas, Jinru Shia, Romane Joseph, et al.
Annals of Surgery|November 17, 2020
A More Extensive Lymphadenectomy Enhances Survival After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal AdenocarcinomaSmita Sihag, Tamar Nobel, Meier Hsu, et al.
Annals of Surgical Oncology|December 28, 2013
Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancersDo Joong Park, Changhwan Yoon, Nicholas Thomas, et al.
Pageof 18